Hordo Christian 4
4 · Sana Biotechnology, Inc. · Filed Sep 7, 2021
Insider Transaction Report
Form 4
Hordo Christian
SVP, Chief Business Officer
Transactions
- Exercise/Conversion
Common Stock
2021-09-02$1.48/sh+6,558$9,706→ 977,356 total - Sale
Common Stock
2021-09-02$25.00/sh−1,400$35,005→ 969,398 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-09-02−6,558→ 128,708 totalExercise: $1.48Exp: 2030-01-26→ Common Stock (6,558 underlying) - Sale
Common Stock
2021-09-02$25.00/sh−6,558$163,962→ 970,798 total - Sale
Common Stock
2021-09-03$25.00/sh−700$17,500→ 969,398 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-09-03−700→ 128,008 totalExercise: $1.48Exp: 2030-01-26→ Common Stock (700 underlying) - Exercise/Conversion
Common Stock
2021-09-03$1.48/sh+700$1,036→ 970,098 total
Footnotes (4)
- [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 4, 2021.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.00 to $25.02, inclusive. The reporting person undertakes to provide to Sana Biotechnology, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.
- [F3]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.00 to $25.015, inclusive.
- [F4]This option began vesting on February 14, 2020, with 25% of the underlying shares becoming vested and exercisable on February 14, 2021 and the remainder of the underlying shares vesting at a rate of 1/36th per month thereafter.